Health Technology Collaboration

REGISTER NOW Imagine an APP for nuclei segmentation that is reliable and can be used by anyone in your lab. Recent advances in deep learning and artificial intelligence have enabled Visiopharm to develop novel tools for nuclei...

The Danish-based leader in augmented pathology solutions Visiopharm has secured a grant worth £250,000 from UK Research and Innovation to test its innovative solutions in partnership with the NHS. The grant, offered by the UK Government’s...

OR

platinum partners

gold partners

Silver Partners

Media Partners